These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24835482)

  • 1. Engineered hair follicle mesenchymal stem cells overexpressing controlled-release insulin reverse hyperglycemia in mice with type L diabetes.
    Wu C; Liu F; Li P; Zhao G; Lan S; Jiang W; Meng X; Tian L; Li G; Li Y; Liu JY
    Cell Transplant; 2015; 24(5):891-907. PubMed ID: 24835482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells.
    Katuchova J; Tothova T; Farkasova Iannaccone S; Toporcer T; Harvanova D; Hildebrand T; Kilik R; Bacenkova D; Frohlichova L; Rosocha J; Bobrov N; Radonak J
    J Surg Res; 2012 Nov; 178(1):188-95. PubMed ID: 22480834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
    Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
    Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
    Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
    Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of mesenchymal stem cells improves type 1 diabetes mellitus.
    Li L; Li F; Gao F; Yang Y; Liu Y; Guo P; Li Y
    Cell Tissue Res; 2016 May; 364(2):345-55. PubMed ID: 26650464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
    Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice.
    Dao LT; Park EY; Lim SM; Choi YS; Jung HS; Jun HS
    Transplantation; 2014 Nov; 98(10):1040-7. PubMed ID: 25208321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of differentiated umbilical cord mesenchymal cells under kidney capsule for control of type I diabetes in rat.
    Moshrefi M; Yari N; Nabipour F; Bazrafshani MR; Nematollahi-mahani SN
    Tissue Cell; 2015 Aug; 47(4):395-405. PubMed ID: 26025422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β engineered mesenchymal stem cells (TGF-β/MSCs) for treatment of Type 1 diabetes (T1D) mice model.
    Daneshmandi S; Karimi MH; Pourfathollah AA
    Int Immunopharmacol; 2017 Mar; 44():191-196. PubMed ID: 28110219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of betatrophin-expressing adipose-derived mesenchymal stem cells induces β-cell proliferation in diabetic mice.
    Sun LL; Liu TJ; Li L; Tang W; Zou JJ; Chen XF; Zheng JY; Jiang BG; Shi YQ
    Int J Mol Med; 2017 Apr; 39(4):936-948. PubMed ID: 28290605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Potential of Adipose-Derived SSEA-3-Positive Muse Cells for Treating Diabetic Skin Ulcers.
    Kinoshita K; Kuno S; Ishimine H; Aoi N; Mineda K; Kato H; Doi K; Kanayama K; Feng J; Mashiko T; Kurisaki A; Yoshimura K
    Stem Cells Transl Med; 2015 Feb; 4(2):146-55. PubMed ID: 25561682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.
    Ezquer F; Ezquer M; Contador D; Ricca M; Simon V; Conget P
    Stem Cells; 2012 Aug; 30(8):1664-74. PubMed ID: 22644660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic Preconditioning Improves the Therapeutic Potential of Aging Bone Marrow Mesenchymal Stem Cells in Streptozotocin-Induced Type-1 Diabetic Mice.
    Waseem M; Khan I; Iqbal H; Eijaz S; Usman S; Ahmed N; Alam G; Salim A
    Cell Reprogram; 2016 Oct; 18(5):344-355. PubMed ID: 27500307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells with modification of junctional adhesion molecule a induce hair formation.
    Wu M; Guo X; Yang L; Wang Y; Tang Y; Yang Y; Liu H
    Stem Cells Transl Med; 2014 Apr; 3(4):481-8. PubMed ID: 24558164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betacellulin overexpression in mesenchymal stem cells induces insulin secretion in vitro and ameliorates streptozotocin-induced hyperglycemia in rats.
    Paz AH; Salton GD; Ayala-Lugo A; Gomes C; Terraciano P; Scalco R; Laurino CC; Passos EP; Schneider MR; Meurer L; Cirne-Lima E
    Stem Cells Dev; 2011 Feb; 20(2):223-32. PubMed ID: 20836700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically engineered K cells provide sufficient insulin to correct hyperglycemia in a nude murine model.
    Zhang Y; Yao L; Shen K; Xu M; Zhou P; Yang W; Liu X; Qin X
    Acta Biochim Biophys Sin (Shanghai); 2008 Feb; 40(2):149-57. PubMed ID: 18235977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of human hair follicle-derived mesenchymal stem cells/CultiSpher(®)-G constructs in regenerative medicine.
    Li P; Liu F; Wu C; Jiang W; Zhao G; Liu L; Bai T; Wang L; Jiang Y; Guo L; Qi X; Kou J; Fan R; Hao D; Lan S; Li Y; Liu JY
    Cell Tissue Res; 2015 Oct; 362(1):69-86. PubMed ID: 25948482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Infusion of Human Adipose Tissue-Derived Mesenchymal Stem Cells to Treat Type 1 Diabetic Mellitus in Mice: An Evaluation of Grafted Cell Doses.
    Dang LT; Bui AN; Le-Thanh Nguyen C; Truong NC; Bui AT; Kim NP; Truong KD; Van Pham P
    Adv Exp Med Biol; 2018; 1083():145-156. PubMed ID: 29423674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.
    Abdi R; Moore R; Sakai S; Donnelly CB; Mounayar M; Sackstein R
    Stem Cells; 2015 May; 33(5):1523-31. PubMed ID: 25641589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-regulated glucose uptake by transplanted muscle cells expressing glucokinase counteracts diabetic hyperglycemia.
    Otaegui PJ; Ontiveros M; Ferre T; Riu E; Jiménez R; Bosch F
    Hum Gene Ther; 2002 Dec; 13(18):2125-33. PubMed ID: 12542844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.